Clinical exome sequencing identifies novel compound heterozygous mutations of the POMT2 gene in patients with limb‐girdle muscular dystrophy
- 7 November 2022
- journal article
- research article
- Published by Wiley in International Journal of Developmental Neuroscience
- Vol. 83 (1), 23-30
- https://doi.org/10.1002/jdn.10233
Abstract
Objective Mutations in protein O-mannosyltransferase 2 (POMT2) (MIM#607439) have been identified in severe congenital muscular dystrophy such as Walker-Warburg syndrome (WWS) and milder limb-girdle muscular dystrophy type 2N (LGMD2N). The aim of this study is to investigate the genetic causes in patients with LGMD2N. Methods Three patients diagnosed with mild limb-girdle muscular dystrophy were recruited. The genetically pathogenic variant was identified by clinical exome sequencing, and healthy controls were verified by Sanger sequencing. Results Novel compound heterozygous mutations c.800A > G and c.1074_1075delinsAT of POMT2 were revealed in one affected individual by clinical exome sequencing. There was no report of these two variants and predicted to be highly damaging to the function of the POMT2. Conclusion The novel variants extend the spectrum of POMT2 mutations, which promotes the prognostic value of testing for POMT2 mutations in patients with LGMD2N.Keywords
This publication has 24 references indexed in Scilit:
- Limb girdle muscular dystrophy due to mutations in POMT2Journal of Neurology, Neurosurgery & Psychiatry, 2017
- Targeted Re-Sequencing Emulsion PCR Panel for Myopathies: Results in 94 CasesJournal of Neuromuscular Diseases, 2016
- Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophyZeitschrift für Neurologie, 2016
- Skeletal muscle MRI of the lower limbs in congenital muscular dystrophy patients with novel POMT1 and POMT2 mutationsNeuromuscular Disorders, 2014
- A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylationEuropean Journal of Paediatric Neurology, 2013
- Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2The Journal of Biochemistry, 2009
- A novel POMT2 mutation causes mild congenital muscular dystrophy with normal brain MRIBrain & Development, 2009
- POMT2 gene mutation in limb-girdle muscular dystrophy with inflammatory changesBiochemical and Biophysical Research Communications, 2007
- Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycanBrain, 2007
- POMT2 mutation in a patient with ‘MEB-like’ phenotypeNeuromuscular Disorders, 2006